KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of RevenueDiaggregated Revenue AnnualDiaggregated Revenue Mix Annual %Disaggregated RevenueDisaggregated Revenue Mix %Employee StatisticsIncome Before Provisions For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProfitability AnnualProperty And Equipment, NetRevenueRevenue AnnualRevenue From PayorsRevenue From Payors AnnualRevenue Mix From Payors %Revenue Mix From Payors Annual %Test Reports DeliveredTest Reports Delivered BreakdownTest Reports Delivered Total
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Cost Of Revenue (2018 - 2025)

Castle Biosciences' Cost of Revenue history spans 7 years, with the latest figure at $18.3 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 13.17% year-over-year to $18.3 million; the TTM value through Dec 2025 reached $71.0 million, up 17.98%, while the annual FY2025 figure was $71.0 million, 17.98% up from the prior year.
  • Cost of Revenue for Q4 2025 was $18.3 million at Castle Biosciences, down from $18.7 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $18.7 million in Q3 2025 and bottomed at $3.0 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $11.3 million (2023), against an average of $11.6 million.
  • The largest annual shift saw Cost of Revenue soared 107.9% in 2022 before it increased 13.17% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $4.6 million in 2021, then surged by 107.09% to $9.5 million in 2022, then soared by 30.49% to $12.4 million in 2023, then surged by 30.27% to $16.2 million in 2024, then increased by 13.17% to $18.3 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Cost of Revenue are $18.3 million (Q4 2025), $18.7 million (Q3 2025), and $17.6 million (Q2 2025).